Otsuka (OTCMKTS:OTSKY) Trading Down 3.8% - Time to Sell?

Key Points

• Otsuka Holdings Co., Ltd. shares declined by 3.8%, closing at $27.70, significantly below its previous close of $28.80.
• The stock is rated a "strong sell" by Zacks Research, and has a consensus rating of "Sell" from analysts.
• Otsuka has a market cap of $29.79 billion and a remarkably low price-to-earnings ratio of 0.18.

Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTCMKTS:OTSKY - Get Free Report)'s share price was down 3.8% during trading on Wednesday . The stock traded as low as $27.70 and last traded at $27.70. Approximately 2,764 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 52,009 shares. The stock had previously closed at $28.80.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Otsuka to a "strong sell" rating in a research report on Monday, August 11th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Otsuka presently has an average rating of "Sell".

Otsuka Stock Performance

The stock has a fifty day moving average price of $25.97 and a 200-day moving average price of $25.05. The firm has a market cap of $29.60 billion and a PE ratio of 0.18.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.